<?xml version="1.0" encoding="UTF-8"?>
<p>On July 3, 2019, the AMED research group had a PMDA workshop “Utilization of pharmacometrics in drug development to meet unmet needs such as pediatric patients and intractable diseases” that is divided into two parts of which the first half provided presentations on ER analysis, and the second half provided presentations on PBPK model analysis. The workshop was attended by ~ 250 participants from industry, academia, and regulatory agency, and has made six presentations by speakers from home and abroad.</p>
